Evidence map›Paper›PMID 35144859›Full record

ArticleMolecular genetics and metabolism2022

PUS7 deficiency in human patients causes profound neurodevelopmental phenotype by dysregulating protein translation.

Sangwoo T Han, Andrew C Kim, Karolyn Garcia, Lisa A Schimmenti, Ellen Macnamara, Undiagnosed Diseases Network, William A Gahl, May C Malicdan, Cynthia J Tifft

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Molecular genetics and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
NCT06092346 recruitingnot on this mapstarted 2023, after this paper: background citation

Prospective Study of the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2023 to 2099Enrolled999ConditionsAMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency, AMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency, TPMT, OMIM *187680, Thoipurines, Poor Metabolism of
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The impact of psuedouridine modification on human tRNA.Biochemical Society transactions · 2026
    Review
  5. Article
  6. Pseudouridine synthase 7 as a context-specific therapeutic target in cancer.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  7. Review
  8. Article
  9. Genetic Profiling of Polymicrogyria in a South Indian Cohort.Annals of Indian Academy of Neurology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sangwoo T HanMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America. Electronic address: ted.han@nih.gov.
Andrew C KimMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America.
Karolyn GarciaMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America.
Lisa A SchimmentiDepartment of Clinical Genomics, Ophthalmology, Otorhinolaryngology, and Biochemistry and Molecular Biology, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55902, United States of America.
Ellen MacnamaraUndiagnosed Diseases Program, Office of the Director, National Institutes of Health, Bethesda, MD 20892, United States of America.
Undiagnosed Diseases NetworkUndiagnosed Diseases Network, Common Fund, Office of the Director, NIH, Bethesda, MD 20892, United States of America.
William A GahlMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America; Undiagnosed Diseases Program, Office of the Director, National Institutes of Health, Bethesda, MD 20892, United States of America.
May C MalicdanMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America; Undiagnosed Diseases Program, Office of the Director, National Institutes of Health, Bethesda, MD 20892, United States of America.
Cynthia J TifftMedical Genetics Branch, National Human Genome Research Institute, Bethesda, MD 20892, United States of America; Undiagnosed Diseases Program, Office of the Director, National Institutes of Health, Bethesda, MD 20892, United States of America.
National Human Genome Research Institute · USOffice of the Director · USMayo Clinic · USNational Institutes of Health · US

Funding

Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
Pathogenesis informs therapy in the GM1 and GM2 GangliosidosesZIAHG200409 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI TIFFT, CYNTHIA · 2020 to 2025
$4.1M
NHGRI/DIR Clinical Support ServicesZ01HG200352 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2008 to 2008
$3.7M
Intramural NIH HHS Z01 HG200352Intramural NIH HHS ZIA HG200409
6 · The paper itself

Abstract

Protein translation is a highly regulated process involving the interaction of numerous genes on every component of the protein translation machinery. Upregulated protein translation is a hallmark of cancer and is implicated in autism spectrum disorder, but the risks of developing each disease do not appear to be correlated with one another. In this study we identified two siblings from the NIH Undiagnosed Diseases Program with loss of function variants in PUS7, a gene previously implicated in the regulation of total protein translation. These patients exhibited a neurodevelopmental phenotype including autism spectrum disorder in the proband. Both patients also had features of Lesch-Nyhan syndrome, including hyperuricemia and self-injurious behavior, but without pathogenic variants in HPRT1. Patient fibroblasts demonstrated upregulation of protein synthesis, including elevated MYC protein, but did not exhibit increased rates of cell proliferation. Interestingly, the dysregulation of protein translation also resulted in mildly decreased levels of HPRT1 protein suggesting an association between dysregulated protein translation and the LNS-like phenotypic findings. These findings strengthen the correlation between neurodevelopmental disease, particularly autism spectrum disorders, and the rate of protein translation.

Indexed as

Autism Spectrum DisorderLesch-Nyhan SyndromeHumansHypoxanthine PhosphoribosyltransferaseIntramolecular TransferasesPhenotypeProtein BiosynthesisProteinsHypoxanthine PhosphoribosyltransferaseIntramolecular TransferasesProteinsPUS7 protein, humanNeurodevelopmental diseaseProtein translationPUS7

Identifiers

PMID35144859
PMCPMC8958514
OpenAlexW4210817610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.